INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹9.91 Cr | ₹9.14 Cr | ₹47 Cr | ₹18 Cr | ₹36 Cr |
What is the latest Long Term Provisions ratio of INNOVA CAPTAB ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹9.91 Cr |
| Mar2024 | ₹9.14 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹18 Cr |
| Mar2021 | ₹36 Cr |
How is Long Term Provisions of INNOVA CAPTAB Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.91 Cr | 8.32 | |
| Mar2024 | ₹9.14 Cr | -80.47 | |
| Mar2023 | ₹47 Cr | 156.83 | |
| Mar2022 | ₹18 Cr | -49.48 | |
| Mar2021 | ₹36 Cr | - | |
Compare Long Term Provisions of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹5,036.2 Cr | 1% | 20.6% | -5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 0.9% | 12.7% | 8.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | -0.4% | 9.7% | 11.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 0.5% | 5.8% | 36.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | -2.7% | 13.9% | -6.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 1.5% | 7.3% | 8% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 1% |
20.6% |
-5.7% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses